The PA Breast Cancer Coalition recently had the honor of awarding $50,000 to researcher Nancy Lill, Ph.D. of Penn State Cancer Institute. Dr. Lill will use the grant on a specialized project targeting the treatment of aggressive triple-negative breast cancers. Her research team plans to advance novel anticancer compounds, known as schweinfurthin analogues, toward the ultimate goal of clinical use against certain cancers that have been resistant to chemotherapy, like triple-negative.
“The funding from the PA Breast Cancer Coalition fills a critical gap in the research pipeline.” said Dr. Lill. “By providing the research resources necessary to undertake such work and generate such evidence, you set the stage for leaps in scientific knowledge that will lead to new and effective treatments for breast cancer patients.”
Dr. Lill hosted a special immersion lab for students from the Harrisburg School District participating in the PBCC CARES (Community, Advocacy and Research Education for Students) program following the award presentation. She explained why triple-negative breast cancers are particularly difficult to treat and showed the students cancer cells through the microscope.
Funding for Dr. Lill’s research grant comes from Pennsylvanians who donate their PA income tax refund, private donors and contributions from the PA Breast Cancer Coalition’s Grassroots Partners.
Would you like to bring us closer to a cure for breast cancer? Donate your state income tax refund to breast cancer research on Line 32 of the PA-40 form or host a Grassroots Partner event in your community! Help us find a cure now… so our daughters won’t have to!